# A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting

> **NCT03448445** · — · COMPLETED · sponsor: **Eisai Korea Inc.** · enrollment: 201 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **OTHER:** Usual care setting

## Key facts

- **NCT ID:** NCT03448445
- **Lead sponsor:** Eisai Korea Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-22
- **Primary completion:** 2021-08-10
- **Final completion:** 2021-08-10
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03448445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03448445, "A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03448445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*